CZ20032540A3 - Synergické kombinace ligandů retinoidního receptoru a vybraných cytotoxických prostředků pro léčení rakoviny - Google Patents
Synergické kombinace ligandů retinoidního receptoru a vybraných cytotoxických prostředků pro léčení rakoviny Download PDFInfo
- Publication number
- CZ20032540A3 CZ20032540A3 CZ20032540A CZ20032540A CZ20032540A3 CZ 20032540 A3 CZ20032540 A3 CZ 20032540A3 CZ 20032540 A CZ20032540 A CZ 20032540A CZ 20032540 A CZ20032540 A CZ 20032540A CZ 20032540 A3 CZ20032540 A3 CZ 20032540A3
- Authority
- CZ
- Czechia
- Prior art keywords
- rar
- formula
- cytotoxic agent
- selected cytotoxic
- paclitaxel
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27775401P | 2001-03-22 | 2001-03-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CZ20032540A3 true CZ20032540A3 (cs) | 2004-05-12 |
Family
ID=23062213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CZ20032540A CZ20032540A3 (cs) | 2001-03-22 | 2002-03-22 | Synergické kombinace ligandů retinoidního receptoru a vybraných cytotoxických prostředků pro léčení rakoviny |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1383491A2 (https=) |
| JP (1) | JP2004528316A (https=) |
| KR (1) | KR20030086314A (https=) |
| CN (1) | CN1498105A (https=) |
| BR (1) | BR0207681A (https=) |
| CA (1) | CA2441335A1 (https=) |
| CZ (1) | CZ20032540A3 (https=) |
| DE (1) | DE02733871T1 (https=) |
| ES (1) | ES2214985T1 (https=) |
| HU (1) | HUP0400255A2 (https=) |
| IL (1) | IL157358A0 (https=) |
| MX (1) | MXPA03008403A (https=) |
| PL (1) | PL368946A1 (https=) |
| TR (1) | TR200400812T3 (https=) |
| WO (1) | WO2002078620A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5113038B2 (ja) * | 2006-03-23 | 2013-01-09 | テムリック株式会社 | 癌治療用キットおよび癌治療用医薬組成物 |
-
2002
- 2002-03-22 WO PCT/US2002/008718 patent/WO2002078620A2/en not_active Ceased
- 2002-03-22 TR TR2004/00812T patent/TR200400812T3/xx unknown
- 2002-03-22 CA CA002441335A patent/CA2441335A1/en not_active Abandoned
- 2002-03-22 IL IL15735802A patent/IL157358A0/xx unknown
- 2002-03-22 DE DE0001383491T patent/DE02733871T1/de active Pending
- 2002-03-22 JP JP2002576888A patent/JP2004528316A/ja not_active Withdrawn
- 2002-03-22 PL PL02368946A patent/PL368946A1/xx not_active Application Discontinuation
- 2002-03-22 HU HU0400255A patent/HUP0400255A2/hu unknown
- 2002-03-22 ES ES02733871T patent/ES2214985T1/es active Pending
- 2002-03-22 BR BR0207681-0A patent/BR0207681A/pt not_active Application Discontinuation
- 2002-03-22 MX MXPA03008403A patent/MXPA03008403A/es unknown
- 2002-03-22 CN CNA028070011A patent/CN1498105A/zh active Pending
- 2002-03-22 KR KR10-2003-7012217A patent/KR20030086314A/ko not_active Withdrawn
- 2002-03-22 EP EP02733871A patent/EP1383491A2/en not_active Withdrawn
- 2002-03-22 CZ CZ20032540A patent/CZ20032540A3/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1498105A (zh) | 2004-05-19 |
| PL368946A1 (pl) | 2005-04-04 |
| IL157358A0 (en) | 2004-02-19 |
| BR0207681A (pt) | 2004-07-27 |
| HUP0400255A2 (hu) | 2004-08-30 |
| KR20030086314A (ko) | 2003-11-07 |
| DE02733871T1 (de) | 2004-08-26 |
| TR200400812T3 (tr) | 2004-07-21 |
| ES2214985T1 (es) | 2004-10-01 |
| JP2004528316A (ja) | 2004-09-16 |
| WO2002078620A2 (en) | 2002-10-10 |
| CA2441335A1 (en) | 2002-10-10 |
| WO2002078620A3 (en) | 2003-04-17 |
| MXPA03008403A (es) | 2004-01-29 |
| EP1383491A2 (en) | 2004-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kou et al. | Arctigenin inhibits lipopolysaccharide-induced iNOS expression in RAW264. 7 cells through suppressing JAK-STAT signal pathway | |
| Heller et al. | Tetra-O-methyl nordihydroguaiaretic acid induces G2 arrest in mammalian cells and exhibits tumoricidal activity in vivo | |
| Wittrant et al. | Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities | |
| Tang et al. | Piceatannol inhibits the IL-1β-induced inflammatory response in human osteoarthritic chondrocytes and ameliorates osteoarthritis in mice by activating Nrf2 | |
| JPH09507050A (ja) | 抗新生物剤としての酪酸、酪酸塩、および誘導体の生理学的に安定な組成物 | |
| Xia et al. | Mangiferin protects osteoblast against oxidative damage by modulation of ERK5/Nrf2 signaling | |
| CN110507655B (zh) | 化合物fg-4592在制备治疗甲状腺激素受体介导疾病的药物制剂中的应用 | |
| Nagpal et al. | Retinoids as anti-cancer agents | |
| Jin et al. | Acacetin inhibits RANKL-induced osteoclastogenesis and LPS-induced bone loss by modulating NFATc1 transcription | |
| CZ20032540A3 (cs) | Synergické kombinace ligandů retinoidního receptoru a vybraných cytotoxických prostředků pro léčení rakoviny | |
| US20040122080A1 (en) | Synergist combinations of retinoid receptor ligands and selected cytotoxic agents for treatment of cancer | |
| US20250375468A1 (en) | Novel ras inhibitors | |
| EP3707127B1 (en) | COMPOUNDS FOR INHIBITING LY6K AND THEIR METHODS OF USE | |
| AU2002305072A1 (en) | Synergistic combinations of retinoid receptor ligands and selected cytotoxic agents for treatment of cancer | |
| Ng et al. | Virus-induced differential expression of nuclear receptors and coregulators in dendritic cells: Implication to interferon production | |
| Li et al. | Virulizin®, a novel immunotherapy agent, stimulates TNFα expression in monocytes/macrophages in vitro and in vivo | |
| EP1804806A2 (en) | Methods and compositions for enhancing degradation of nuclear receptor transcription factors and uses thereof | |
| JP4904498B2 (ja) | Ｒａｒ活性化を起こす天然化合物 | |
| KR20140129616A (ko) | 골 형성 과정에서 인간 작은 류신 지퍼 단백질의 용도 | |
| Mathisen et al. | Delayed translocation of NGFI–B/RXR in glutamate stimulated neurons allows late protection by 9-cis retinoic acid | |
| WO2022185742A1 (ja) | 播種性血管内凝固症候群の予防又は治療用組成物 | |
| CN118593523A (zh) | 积雪草苷在制备治疗嘧霉胺中毒药物中的应用 | |
| EP4536203A1 (en) | Diaminoacridine derivatives as inhibitors of ras | |
| WO2023242107A1 (en) | Novel ras inhibitors | |
| WO2025228442A1 (zh) | 氯苯唑酸在激活rxr活性中的用途 |